Tag Archives: tuberculosis

FDA Approves Pretomanid for Highly Drug-Resistant Forms of Tuberculosis

FDA Approves Pretomanid for Highly Drug-Resistant Forms of Tuberculosis Print this page NEW YORK August 14, 2019 – Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the most drug-resistant forms of tuberculosis (TB).1 The new drug was… Read More »